| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2008 | CA2674589A1 Antiviral nucleoside analogs |
| 07/24/2008 | CA2674573A1 Substituted spirochromanone derivatives |
| 07/24/2008 | CA2674563A1 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 07/24/2008 | CA2674539A1 Use of modified oligo-.beta.-(1,3)-glucanes for treating diseases of the immune system, oligo-.beta.-(1,3v-glucane-(1,3)- mannose, oligo-.beta.-(1,3)-glucane-(1,3)- mannitol and derivatives thereof, methods for preparing the same and drugs containing them |
| 07/24/2008 | CA2674530A1 Spirochromanon derivatives |
| 07/24/2008 | CA2674440A1 Methods for improved stability of steroid derivatives |
| 07/24/2008 | CA2674303A1 Therapeutical uses of eslicarbazepine |
| 07/24/2008 | CA2673761A1 Substituted 3-phenyl-1-(phenylthienyl)propan-1-one and 3-phenyl-1-(phenylfuranyl)propan-1-one derivatives, and preparation and use of same |
| 07/24/2008 | CA2673485A1 Gastric retention-type sustained-release levodopa preparation |
| 07/24/2008 | CA2672432A1 Cream-gel comprising at least one retinoid and benzoyl peroxide |
| 07/24/2008 | CA2672430A1 Emulsion comprising at least one retinoid and benzoyl peroxide |
| 07/24/2008 | CA2672425A1 Galenic form for the transmucosal delivery of paracetamol |
| 07/24/2008 | CA2672290A1 Antiviral compounds and methods of using thereof |
| 07/24/2008 | CA2659858A1 Liposome treatment of viral infections |
| 07/24/2008 | CA2648388A1 Treating cancer using electromagnetic fields in combination with other treatment regimens |
| 07/23/2008 | EP1947192A2 Preventive/remedy for arteriosclerotic disease and method of evaluating therapeutic procedure |
| 07/23/2008 | EP1947189A2 Method of vitamin production |
| 07/23/2008 | EP1947185A1 HCV NS3/4A encoding nucleic acid |
| 07/23/2008 | EP1947183A1 Mammalian cell surface antigens; related reagents |
| 07/23/2008 | EP1947120A1 Iron-carbohydrate complex compounds |
| 07/23/2008 | EP1947119A2 Treatment of cancer with anti-erb2 antibodies in combination with a chemotherapeutic agent |
| 07/23/2008 | EP1947117A2 Glycoprotein hormone superagonists |
| 07/23/2008 | EP1947108A1 TGR5 modulators and methods of use thereof |
| 07/23/2008 | EP1947106A1 Streptococcus pneumoniae methionyl tRNA synthetase |
| 07/23/2008 | EP1947103A1 Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments |
| 07/23/2008 | EP1947102A1 Compositions comprising diazepinoindole derivatives as kinase inhibitors |
| 07/23/2008 | EP1947101A1 Hydrazide compound and thrombopoietin receptor activator |
| 07/23/2008 | EP1947100A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 07/23/2008 | EP1947099A1 Process for solvent removal from omeprazole salts |
| 07/23/2008 | EP1947093A1 Substituted morpholine and thiomorpholine derivatives |
| 07/23/2008 | EP1947091A1 Pyrimidyl nitrile derivatives as cysteine protease inhibitors |
| 07/23/2008 | EP1947089A1 A-polymorph of a substituted pyrazoline, its preparation and use as medicaments |
| 07/23/2008 | EP1947088A1 Substituted pyrazoline compounds with ACAT inhibition activity, their preparation and use as medicaments |
| 07/23/2008 | EP1947086A1 Benzene derivative or salt thereof |
| 07/23/2008 | EP1947085A1 Substituted indole sulfonamide compounds, their preparation and use as medicaments |
| 07/23/2008 | EP1946798A1 Compositions containing retinoid and chromenone derivatives |
| 07/23/2008 | EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection |
| 07/23/2008 | EP1946765A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 07/23/2008 | EP1946763A1 Promoter for recovery from anesthesia |
| 07/23/2008 | EP1946761A1 Carrier composition for nucleic acid transport |
| 07/23/2008 | EP1946760A1 Composition for improving intestinal flora |
| 07/23/2008 | EP1946759A1 Therapeutic agent for nausea and/or vomiting |
| 07/23/2008 | EP1946758A1 Treatment of acute myeloid leukemia |
| 07/23/2008 | EP1946757A1 Atr inhibitor |
| 07/23/2008 | EP1946756A1 Use of entacapone in cosmetic, dermatological and pharmaceutical compositions |
| 07/23/2008 | EP1946755A1 Jelly composition |
| 07/23/2008 | EP1946754A1 Therapeutic agent for ulcerative colitis and/or crohn's disease |
| 07/23/2008 | EP1946753A1 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| 07/23/2008 | EP1946752A1 Anti-allergic agent |
| 07/23/2008 | EP1946749A1 Anti-angionene compositions and methods of use |
| 07/23/2008 | EP1946747A1 Pharmaceutical composition of improved stability containing taxane derivatives |
| 07/23/2008 | EP1946007A2 Anbrosteeone derivatives and method of use thereof |
| 07/23/2008 | EP1945734A2 Polycationic viscoelastic compositions |
| 07/23/2008 | EP1945654A2 Preparation of an antibiotic crystalline fusidic acid |
| 07/23/2008 | EP1945652A1 Macrolones |
| 07/23/2008 | EP1945651A1 Analogs of alpha galactosylceramide and uses thereof |
| 07/23/2008 | EP1945648A1 Derivatives of 4,6-disubstituted 1,2,4-triazolo-1,3,4-thiadiazole, a process and uses thereof |
| 07/23/2008 | EP1945646A1 Pyrimidine compounds for the treatment of inflammatory disorders |
| 07/23/2008 | EP1945644A2 Imidazopyrazines as protein kinase inhibitors |
| 07/23/2008 | EP1945643A2 Imidazopyrazines as cyclin dependent kinase inhibitors |
| 07/23/2008 | EP1945642A1 Pyrazolo-pyrimidine derivatives as anti-inflammatory agents |
| 07/23/2008 | EP1945641A1 Hepatitis c virus inhibitors |
| 07/23/2008 | EP1945639A1 Tetrahydronaphthyridine derivative |
| 07/23/2008 | EP1945638A2 Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1h-[1,8]naphthyridin-2-one |
| 07/23/2008 | EP1945637A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 07/23/2008 | EP1945635A2 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 07/23/2008 | EP1945634A1 Phenylenebisoxazolidine derivatives and their use as anticoagulants |
| 07/23/2008 | EP1945633A1 Compounds and compositions as ppar modulators |
| 07/23/2008 | EP1945632A1 Heterocyclic modulators of atp-binding cassette transporters |
| 07/23/2008 | EP1945631A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 07/23/2008 | EP1945630A2 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 07/23/2008 | EP1945628A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/23/2008 | EP1945627A1 Pyrimidine derivatives for the treatment of cancer |
| 07/23/2008 | EP1945626A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 07/23/2008 | EP1945624A1 Chroman compounds as 5-ht1b antagonists |
| 07/23/2008 | EP1945623A2 Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same |
| 07/23/2008 | EP1945620A2 Compounds and compositions as ppar modulators |
| 07/23/2008 | EP1945617A2 Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
| 07/23/2008 | EP1945616A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 07/23/2008 | EP1945613A1 Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of copd and asthma |
| 07/23/2008 | EP1945612A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1945606A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof |
| 07/23/2008 | EP1945305A2 Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases |
| 07/23/2008 | EP1945304A2 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 07/23/2008 | EP1945270A2 Compositions and methods for inhibiting expression of factor v leiden mutant gene |
| 07/23/2008 | EP1945267A2 Small interfering oligonucleotides comprising arabinose modified nucleotides |
| 07/23/2008 | EP1945265A1 Antiproliferative combination comprising cyc-682 and a cytotoxic agent |
| 07/23/2008 | EP1945256A1 Methods and compositions for modulating wound repair |
| 07/23/2008 | EP1945246A2 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 07/23/2008 | EP1945244A2 Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions |
| 07/23/2008 | EP1945243A1 Use of calcitonin for the treatment of ra |
| 07/23/2008 | EP1945233A2 Dual-phase cement precursor systems for bone repair |
| 07/23/2008 | EP1945232A2 Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and egfr inhibitors or pyrimidine analogues |
| 07/23/2008 | EP1945231A2 Conformable solvent-based bandage and coating material |
| 07/23/2008 | EP1945230A1 Anti-misuse microparticulate oral pharmaceutical form |
| 07/23/2008 | EP1945229A2 Methods for fabrication of antimicrobial surfaces |
| 07/23/2008 | EP1945228A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 07/23/2008 | EP1945227A2 Azithromycin for treatment of granulomatous rosacea |
| 07/23/2008 | EP1945226A2 Drug composition with analgesic, anti-inflammatory and decongestive activity |